Dec
14

Life Expectancy Rises Around World, Study Finds

A sharp decline in deaths from malnutrition and infectious diseases like measles and tuberculosis has caused a shift in global mortality patterns over the past 20 years, according to a report published on Thursday, with far more of the world’s population now living into old age and dying from diseases mostly associated with rich countries, like cancer and heart disease. Tony Karumba/Agence...
Read More..

On Instagram, a Thriving Bazaar Taps a Big Market

Instagram, the picture-sharing application that Facebook bought earlier this year, has not yet figured out a way to make money. But some of its users have. Peter DaSilva for The New York TimesServices like Prinstagram let people turn their Instagram images into prints, wall calendars and stickers. These entrepreneurs have realized that they can piggyback...
Read More..
Dec
13

Rice Ends Bid to Succeed Clinton as Secretary of State

WASHINGTON — President Obama knew before he picked up the phone on Thursday afternoon what Susan E. Rice, his ambassador to the United Nations, was calling about: she wanted to take herself out of the running for secretary of state and spare him a fight. By acceding to Ms. Rice’s request, which she had conveyed to White House aides the night before, Mr. Obama averted a bitter, potentially...
Read More..

N. Joseph Woodland, Inventor of the Bar Code, Dies at 91

N. Joseph Woodland, who six decades ago drew a set of lines in the sand and in the process conceived the modern bar code, died on Sunday at his home in Edgewater, N.J. He was 91. His daughter Susan Woodland confirmed the death. A retired mechanical engineer, Mr. Woodland was a graduate student when he and a classmate, Bernard Silver, created a technology — based on a printed series...
Read More..

My Story: Taking on Cancer Again, This Time With the Wisdom of Age

After I finished eight months of treatment for testicular cancer in my mid-20s, my psychologist said, “Well, that was like having five years of therapy all at once.” What he meant was that you learn a lot about yourself in weekly talk sessions, but during a life-threatening illness, the “issues” come at you nonstop. I relished the slow unfolding of myself in the first, but I resented — no, hated —...
Read More..

My Story: Taking on Cancer Again, This Time With the Wisdom of Age

After I finished eight months of treatment for testicular cancer in my mid-20s, my psychologist said, “Well, that was like having five years of therapy all at once.” What he meant was that you learn a lot about yourself in weekly talk sessions, but during a life-threatening illness, the “issues” come at you nonstop. I relished the slow unfolding of myself in the first, but I resented — no, hated —...
Read More..
Dec
12

10 Arrested in Theft of Personal Data

International authorities, with some help from Facebook, have arrested 10 people accused of operating a network of infected computers that stole personal information from millions of victims. The Justice Department said Tuesday night that the F.B.I. and international agencies were helped in their investigations by Facebook, whose users were among those targeted by the malware, or malicious...
Read More..

10 Arrested in Theft of Personal Data

International authorities, with some help from Facebook, have arrested 10 people accused of operating a network of infected computers that stole personal information from millions of victims. The Justice Department said Tuesday night that the F.B.I. and international agencies were helped in their investigations by Facebook, whose users were among those targeted by the malware, or malicious...
Read More..

Eli Lilly to Conduct Additional Study of Alzheimer’s Drug

The drug maker Eli Lilly & Company said on Wednesday that it planned an additional study of an experimental Alzheimer’s drug that failed to improve the condition of people with the disease, saying that it remained hopeful about the drug’s prospects. The newest study is expected to get under way in the third quarter of 2013 and will focus on patients with mild Alzheimer’s disease. Lilly...
Read More..

Eli Lilly to Conduct Additional Study of Alzheimer’s Drug

The drug maker Eli Lilly & Company said on Wednesday that it planned an additional study of an experimental Alzheimer’s drug that failed to improve the condition of people with the disease, saying that it remained hopeful about the drug’s prospects. The newest study is expected to get under way in the third quarter of 2013 and will focus on patients with mild Alzheimer’s disease. Lilly...
Read More..